Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Glas
Annuska Maria Glas, Assendelft NL
| Patent application number | Description | Published |
|---|---|---|
| 20100184052 | PROGNOSTIC GENE EXPRESSION SIGNATURE FOR NON SMALL CELL LUNG CANCER PATIENTS - The invention relates to a method of typing non-small cell lung cancer cells by determining RNA levels for a set of genes. Said typing can be used for determining a metastasizing potential of the cancer cells. The invention further relates to a set of probes and a set of primers that can be used for typing non-small cell lung cancer cells. | 07-22-2010 |
| 20110269127 | MEANS AND METHOD FOR DETERMINING TUMOR CELL PERCENTAGE IN A SAMPLE - The invention provides a method for determining the percentage of tumor cells in a sample of an individual, preferably a breast sample. More specifically, the invention provides one or more genes than can be used to determine the percentage of tumor cells. The invention further provides a set of probes, a set of primers, and uses thereof for detection of said one or more genes. | 11-03-2011 |
| 20110319285 | METHODS AND MEANS FOR TYPING A SAMPLE COMPRISING COLORECTAL CANCER CELLS - The invention relates to a method of typing colorectal cancer cells by determining the RNA levels of a set of signature genes. Said typing can be use for predicting a risk for recurrence of said colorectal cancer. The invention further relates to a set of genes that can be used for normalizing the RNA levels of said set of signature genes, and to micro-array comprising said set of signature genes. | 12-29-2011 |
Annuska Maria Glas, Uitgeest NL
| Patent application number | Description | Published |
|---|---|---|
| 20100130374 | HIGH-THROUGHPUT DIAGNOSTIC TESTING USING ARRAYS - The present invention relates to arrays comprising between 2 and 12.000 nucleic acid molecules, comprising a first set of nucleic acid molecules that comprise a nucleotide sequence that is able to hybridize to a gene that is used for normalization. The array may further comprise a second set of nucleic acid molecules that comprise nucleic acid sequences capable of hybridizing to nucleic acid molecules that are expressed in clinical relevant samples such as, for example, breast tissue. The invention further relates to a method for normalizing data. Further provided are methods of using an array according to the invention for distinguishing clinical samples. | 05-27-2010 |
Barry Glas, Carmel, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20090126968 | Screwless wall-plate - The present invention provides for a screwless wall-plate assembly which includes a base plate component, at least two barbed fastener components, and a face plate component irremovably attached to the base plate component. The base plate component has a central opening for receiving at least one electrical component and at least two openings to receive the fastener components. The fastener component is fitted through the base plate and is sized to mate with the openings in a standard yoke or mounting strap electrical device. The face plate component has at least one opening configured to accommodate a gang device body and is permanently affixed to the front of the base plate. Once the screwless wall-plate is fully assembled, the fasteners provide secure yet removable means of affixing the screwless wall-plate to a standard yoke or strap mounting electrical device, thereby completing enclosure of the wired device inside the electrical box. | 05-21-2009 |
Cornelis Glas, Tytsjerk NL
| Patent application number | Description | Published |
|---|---|---|
| 20090181103 | CHOLESTEROL-LOWERING DAIRY PRODUCTS AND METHODS FOR THEIR PREPARATION - The invention relates to a concentrated or dried milk product having cholesterol-lowering effects and to methods for preparing the same. Provided is a process for the preparation of a milk concentrate or milk powder having a cholesterol-lowering effect, comprising :—preparing a milk liquid;—preparing a fat fraction comprising at least one sterol; and—subjecting the milk liquid to an evaporation procedure, during which procedure the fat fraction is added to the milk liquid before, in or after the liquid collector of one or more effects of the evaporator. Also provided is the product obtainable thereby. | 07-16-2009 |
Cornelis Glas, Tietjerk NL
| Patent application number | Description | Published |
|---|---|---|
| 20100047393 | PROBIOTIC (INFANT) FOOD - The invention relates to foods, such as infants and children's food and dietary supplements for infants and children. The invention provides a composition comprising a lipid source, a carbohydrate source and a protein source, characterized in that the composition further contains the | 02-25-2010 |
| 20100168017 | FUNCTIONAL SERUM PROTEIN PRODUCT FOR USE IN INFANT FOOD AND THERAPEUTIC COMPOSITIONS AND METHODS FOR THE PREPARATION THEREOF - The invention relates to a serum protein product, suitable as an ingredient for foods and therapeutic compositions, in particular infant and baby foods. The invention also provides a method for the preparation of the serum protein product, based on micro filtration of milk. The invention provides a method for the preparation of a serum protein product, comprising the preparation of a permeate through micro filtration of cow's milk at a temperature of between 10 and 20° C. utilizing a membrane having a pore size of between 0.3 and 0.5 μm. | 07-01-2010 |
| 20110281012 | FUNCTIONAL SERUM PROTEIN PRODUCT FOR USE IN INFANT FOOD AND THERAPEUTIC COMPOSITIONS AND METHODS FOR THE PREPARATION THEREOF - The invention relates to a serum protein product, suitable as an ingredient for foods and therapeutic compositions, in particular infant and baby foods. The invention also provides a method for the preparation of the serum protein product, based on micro filtration of milk. The invention provides a method for the preparation of a serum protein product, comprising the preparation of a permeate through micro filtration of cow's milk at a temperature of between 10 and 20° C. utilizing a membrane having a pore size of between 0.3 and 0.5 μm. | 11-17-2011 |
Edward D. Glas, Raleigh, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20110282642 | NETWORK EMULATION IN MANUAL AND AUTOMATED TESTING TOOLS - A network emulation system is described herein that allows a software developer to accurately simulate different network characteristics while testing an application, framework, or other software code on a single or multiple computers. The system also provides an ability to record a real network's characteristics and apply those characteristics during a test. The network emulation system integrates a network emulation facility into test tools for both manual and automated tests and allows an application, framework, or other software code to be tested while operating under varying networking conditions such as bandwidth, latency, packet reordering and duplication, disconnection, and so forth. Thus, the network emulation system allows a software developer testing software code to quickly and easily determine how the software code will perform in a variety of real-world networking situations without physically setting up each of those situations. | 11-17-2011 |
Gene Glas, Union Grove, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090011873 | ARTIFICIAL PITCHING SURFACE - An artificial pitching mound. The artificial pitching mound includes an artificial pitching rubber and artificial pitching stride component fillable with microbeads or pellets. The artificial pitching mound reduces repetitive movement injuries for baseball and softball pitchers. The artificial pitching mound also allows positive muscle memory development with a surface that duplicates the feel of natural turf during practice session and allows the athlete's muscles to react the same on both the artificial surface and natural turf. | 01-08-2009 |
Jantien Glas, Hoogkarspel NL
| Patent application number | Description | Published |
|---|---|---|
| 20120065060 | SEED COATING COMPOSITION - The invention is directed to a seed coating composition, to a seed coating cocktail, to a method for preparing a coated seed, to a coated seed, and to the use of specific inorganic particles. The seed coating composition for a seed comprises water and at least 35 wt. % by weight of the coating composition of inorganic particles, wherein the mean particle size (D50) of said inorganic particles as measured by laser obscuration time technology is 250 μm or less. | 03-15-2012 |
John Jerry Glas, Metairie, LA US
| Patent application number | Description | Published |
|---|---|---|
| 20110131053 | SYSTEM AND METHOD FOR EXERCISING PEREMPTORY CHALLENGES DURING JURY SELECTION - A system and method is provided for determining whether an attorney should exercise a peremptory challenge to excuse a prospective juror based on, for example: (1) the location of the juror in the selection order; (2) the rank or score assigned to each potential peremptory challenge; (3) the jurors identified as potential challenges for cause; (4) the probability of dismissal assigned to each potential challenge for cause; (5) the number of jurors needed to serve on the jury; (6) the number of peremptory challenges allowed by the court; (7) the number of jurors in the panel; and (8) the jurors who have already been selected, dismissed for cause, or peremptorily challenged. | 06-02-2011 |
Luc Glas, Louvain-La-Neuve BE
| Patent application number | Description | Published |
|---|---|---|
| 20100140837 | MOULD AND PROCESS FOR SHAPING A SULPHUR CEMENT PRODUCT - The present invention provides a mould for shaping a sulphur cement product, which mould has an inner surface describing an inner volume for receiving a cast material, an outer surface and a barrier comprised between the inner surface and the outer surface, which barrier has a thermal conductance per unit area of at most 100 W/m | 06-10-2010 |
Rickard Glas, Stockholm SE
| Patent application number | Description | Published |
|---|---|---|
| 20100168038 | USE OF COMPOUNDS IN COMBINATION WITH GAMMA-IRRADIATION FOR THE TREATMENT OF CANCER - TPP II (tripeptidyl peptidase inhibitors are useful in enhancing the efficacy of gamma-irradiation cancer therapy or increasing the in vivo gamma-irradiation susceptibility of tumour cells. Suitable compounds comprise tripeptide compounds of general formula R | 07-01-2010 |
| 20100240591 | TPP II INHIBITORS FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AND TRANSPLANT REJECTION - TPP II (tripeptidyl peptidase II) inhibitors are useful in the treatment of autoimmune and/or inflammatory diseases, for example Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis, Sjögrens Syndrome, Diabetes Mellitus Type I or II, Psoriasis, Eczema, Ulcerous Colitis, and Chron's Disease, or transplant rejection. Suitable compounds comprise tripeptide compounds of general formula R | 09-23-2010 |
Uri Glas, Vancouver, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100033750 | Method and Apparatus for Detecting an Inconsistency in Dual Sided Printing - A dual engine printer comprises two print engines, and identical spread data is forwarded to each of the print engines, although each engine prints only one side of the sheet. Each print engine comprises a signature extractor for extracting a signature representative of the spread data it receives, and the printer is able to compare the two signatures to verify that the spread data is identical. The printer is thus able to detect data corruption or alternatively, if the signature extraction is synchronized with the print engage, the printer can verify that both sides are being printed on the same sheet. | 02-11-2010 |